Experiences of treatment in patients with major depressive disorder: a qualitative analysis.

被引：0
|
作者：
Laranjeira, C. [1 ]
机构：
[1] Piaget Inst RECI I&D, Higher Sch Hlth Sci, Viseu, Portugal
来源：
EUROPEAN PSYCHIATRY | 2020年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
EPP0404
引用
收藏
页码：S113 / S114
页数：2
相关论文
共 50 条
  • [31] Personality Modulates the Efficacy of Treatment in Patients With Major Depressive Disorder
    Wardenaar, Klaas J.
    Conradi, Henk Jan
    Bos, Elisabeth H.
    de Jonge, Peter
    JOURNAL OF CLINICAL PSYCHIATRY, 2014, 75 (09) : E916 - E923
  • [32] Dextromethorphan/Bupropion: A Novel Treatment for Patients With Major Depressive Disorder
    Willett, Kristine C.
    Bond, LeDea R.
    Morrill, Amanda M.
    Lorena, Dima
    Petru, Ifteni
    AMERICAN JOURNAL OF THERAPEUTICS, 2024, 31 (01) : e24 - e29
  • [33] Safety of quetiapine for treatment of insomnia in patients with major depressive disorder
    Lee, S.
    Han, J. H.
    Hong, S. C.
    Jeong, J. H.
    Seo, H. J.
    Lim, H. K.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S377 - S378
  • [34] Treatment of night eating syndrome in patients with major depressive disorder
    Makhortova, I. S.
    Tsygankov, B. D.
    Shiryaev, O. U.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S390 - S390
  • [35] Quality of life among Iranian major depressive disorder patients: a qualitative study
    Rezaiye, Milad
    Radfar, Moloud
    MaslakPak, Masumeh Hemmati
    MIDDLE EAST CURRENT PSYCHIATRY-MECPSYCH, 2023, 30 (01):
  • [36] Quality of life among Iranian major depressive disorder patients: a qualitative study
    Milad Rezaiye
    Moloud Radfar
    Masumeh Hemmati MaslakPak
    Middle East Current Psychiatry, 30
  • [37] A COST UTILITY ANALYSIS OF ZURANOLONE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER
    Kim, H. S.
    Cheng, S. Y.
    Ballreich, J.
    Levy, J.
    VALUE IN HEALTH, 2024, 27 (06) : S83 - S83
  • [38] BUDGET IMPACT ANALYSIS OF DULOXETINE IN TREATMENT OF MAJOR DEPRESSIVE DISORDER
    Gwiosda, B.
    Rutkowski, J.
    Rys, P.
    Plisko, R.
    Wladysiuk, M.
    Cel, M.
    Mierzejewski, P.
    Bartminski, W.
    VALUE IN HEALTH, 2009, 12 (07) : A354 - A354
  • [39] PHARMACOECONOMIC ANALYSIS OF AGOMELATINE FOR THE TREATMENT OF MAJOR DEPRESSIVE DISORDER IN KAZAKHSTAN
    Adilgozhina, G.
    Abdukhakimova, D.
    Zhumagali, Y.
    Bektur, C.
    Kostuyk, A.
    Nurgozhin, T.
    VALUE IN HEALTH, 2017, 20 (05) : A297 - A297
  • [40] Escitalopram in the treatment of major depressive disorder: A meta-analysis
    Kennedy, Sidney H.
    Andersen, Henning F.
    Thase, Michael E.
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (01) : 161 - 175
12345